MedTrace Logo

Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study

NCT00258609 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2019-02-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether 120 Unit, and 240 unit of botulinum toxin A are effective in the treatment of migraine without aura prophylaxis.

Conditions

  • Migraine Without Aura Prophylaxis

Interventions

DRUG

Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injection

Sponsors & Collaborators

  • Ipsen

    collaborator INDUSTRY

  • Chiang Mai University

    collaborator OTHER

  • Department of Medical Services Ministry of Public Health of Thailand

    lead OTHER_GOV

Principal Investigators

  • Siwaporn Chankrachang, MD · Northern Neurological Center, Faculty of Medicine,Chiang Mai University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Completion
2004-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00258609 on ClinicalTrials.gov